Published in Pharma Investments, Ventures and Law Weekly, May 16th, 2004
The selling security holders advised the company that, as of April 12, 2004, they have not determined the specific amount, price or timing of any sales of their securities and that they will determine any such sales using the registration statement in their sole discretion.
In compliance with standard registration procedures, the registration statement, once declared effective by the Securities and Exchange Commission, will cover future sales of shares of the company's common stock and warrants, as applicable, held...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.